form8k111407.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported):
November 14, 2007
MERIDIAN
BIOSCIENCE, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Ohio
|
0-14902
|
31-0888197
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No. )
|
3471
River Hills Drive, Cincinnati, Ohio
|
|
45244
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (513)
271-3700
|
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions (see General Instruction A.2.
below):
r Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
r Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
r Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
2.02. Results of Operations and
Financial Condition.
On
November 14, 2007, the Registrant issued a press release announcing its
financial results for the fiscal quarter and year ended September 30,
2007. A copy of the press release is furnished as Exhibit 99 to this
report and is incorporated herein by reference.
Item
9.01. Financial Statements and
Exhibits.
(d) Exhibits
|
99
|
Press
Release dated November 14, 2007
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
MERIDIAN
BIOSCIENCE,
INC. |
|
|
|
|
|
Date:
November 20, 2007
|
By:
|
/s/
Melissa Lueke |
|
|
|
Melissa
Lueke |
|
|
|
Vice President
and
Chief Financial Officer
(Principal Accounting Officer)
|
|
|
|
|
|